Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.39 |
| ▸ | PNMT | P11086 | 1/20 | 0.39 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11029873 | 0.97 | TAAR1 (0.48) | TAAR1AKR1B1SMN1; SMN2CYP1A2CYP2A6 | |
| SCHEMBL29649325 | 0.85 | TAAR1 (0.43) | TAAR1AKR1B1SMN1; SMN2CYP1A2CYP2A6 | |
| SCHEMBL1294517 | 0.85 | TAAR1 (0.43) | TAAR1AKR1B1SMN1; SMN2CYP1A2CYP2A6 | |
| SCHEMBL695878 | 0.85 | TAAR1 (0.43) | TAAR1AKR1B1SMN1; SMN2CYP1A2CYP2A6 | |
| SCHEMBL6358890 | 0.83 | TAAR1 (0.41) | TAAR1AKR1B1SMN1; SMN2LMNAGAA | |
| SCHEMBL1627393 | 0.83 | TAAR1 (0.41) | TAAR1AKR1B1SMN1; SMN2CYP1A2CYP2A6 | |
| SCHEMBL29713144 | 0.83 | TAAR1 (0.61) | TAAR1SMN1; SMN2CYP1A2LMNAGAA | |
| SCHEMBL31454412 | 0.83 | TAAR1 (0.41) | TAAR1AKR1B1SMN1; SMN2CYP1A2CYP2A6 | |
| SCHEMBL4706 | 0.83 | TAAR1 (0.61) | TAAR1SMN1; SMN2CYP1A2LMNAGAA | |
| SCHEMBL7828184 | 0.82 | TDP1 (0.48) | TAAR1AKR1B1SMN1; SMN2LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4640672-A1 | ETHYLENEDIAMINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Jiangsu Protelight Pharmaceutical & Biotechnology Co., Ltd. (CN) | 2025-10-29 | — | — | EP | claimed |
| CN-115784972-B | Ethylenediamine derivative and preparation method and application thereof | 江苏普莱医药生物技术有限公司 | 2025-04-11 | — | — | CN | claimed |
| WO-2024130690-A1 | ETHYLENEDIAMINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 江苏普莱医药生物技术有限公司 | 2024-06-27 | — | — | WO | claimed |
| CN-115784972-A | Ethylene diamine derivative and preparation method and application thereof | 江苏普莱医药生物技术有限公司 | 2023-03-14 | — | — | CN | claimed |
| EP-4013398-A1 | AN IMPROVED PROCESS FOR PREPARATION OF VILANTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Melody Healthcare Pvt. Ltd. (IN) | 2022-06-22 | — | — | EP | claimed |
| CN-114409524-A | Preparation method of 2, 6-dichlorophenylacetic acid | 上海柏狮生物科技有限公司 | 2022-04-29 | — | — | CN | claimed |
| WO-2021033198-A1 | AN IMPROVED PROCESS FOR PREPARATION OF VILANTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | Melody Healthcare Pvt. Ltd (IN) | 2021-02-25 | — | — | WO | claimed |
| US-20010039349-A1 | Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds | SHELL OIL COMPANY | 2001-11-08 | — | — | US | claimed |
| US-12570609-B2 | Tricyclic sulfones as ROR gamma modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-03-10 | — | — | US | disclosed |
| US-20260022094-A1 | Compounds for the Treatment of Neurodegenerative Diseases | CELGENE CORPORATION (US) | 2026-01-22 | — | — | US | disclosed |
| EP-4640672-A1 | ETHYLENEDIAMINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Jiangsu Protelight Pharmaceutical & Biotechnology Co., Ltd. (CN) | 2025-10-29 | — | — | EP | disclosed |
| US-12410142-B2 | Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof | XIAMEN VIVOHEALTHS TECHNOLOGY CO., LTD. (CN) | 2025-09-09 | — | — | US | disclosed |
| US-20250228865-A1 | COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME | SANOFI US SERVICES INC. (US) | 2025-07-17 | — | — | US | disclosed |
| US-12357612-B2 | Prophylactic or therapeutic agent for cancer | TOHOKU UNIVERSITY (JP) | 2025-07-15 | — | — | US | disclosed |
| US-4241079-A | ANTHELMINTICS AND FUNGICIDES | ROHM AND HAAS COMPANY (US) | 1980-12-23 | — | — | US | disclosed |
| US-4172834-A | ANALGESICS, ANTIHISTAMINES AND PSYCHOTROPIC AGENTS | STERLING DRUG INC. (US) | 1979-10-30 | — | — | US | disclosed |
| US-4170650-A | Oxopiperazinium salts, their preparation and their use | THE DOW CHEMICAL COMPANY (US) | 1979-10-09 | — | — | US | disclosed |
| US-4077982-A | HERBICIDES | FMC CORPORATION (US) | 1978-03-07 | — | — | US | disclosed |
| US-4062864-A | ANALGESIC, PSYCHOTROPIC, ANTIHISTAMINE | STERLING DRUG INC. (US) | 1977-12-13 | — | — | US | disclosed |
| US-3959309-A | ANALGESICS, PSYCHOTROPIC, ANTIHISTAMINE | STERLING DRUG INC. (US) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570609-B2 | Tricyclic sulfones as ROR gamma modulators | RORC, RORB, RORA | TAAR1 272/4885AKR1B1 1347/4885SMN1; SMN2 1107/4885 |
| US-12357612-B2 | Prophylactic or therapeutic agent for cancer | TSG101, FABP2, BRCA1 | TAAR1 4550/4885AKR1B1 579/4885SMN1; SMN2 4272/4885 |
| US-20260022094-A1 | Compounds for the Treatment of Neurodegenerative Diseases | S1PR5, CLN6, S1PR1 | TAAR1 172/4885AKR1B1 1794/4885SMN1; SMN2 37/4885 |
| US-20250228865-A1 | COMPOUNDS FOR ENHANCING READ THROUGH OF GENES CONTAINING PREMATURE TERMINATION CODONS AND METHODS FOR MAKING AND USING THE SAME | UPF1, NUDT21, RNGTT | TAAR1 3612/4885AKR1B1 2484/4885SMN1; SMN2 1143/4885 |
| US-12410142-B2 | Substituted imidazole salt compounds, preparation method thereof, pharmaceutical composition thereof and application thereof | ALDOA, IDE, ACAT1 | TAAR1 2711/4885AKR1B1 29/4885SMN1; SMN2 433/4885 |
| US-20010039349-A1 | Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds | AHR, PAH, HRH3 | TAAR1 1113/4885AKR1B1 2216/4885SMN1; SMN2 4511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.